Lee Ainslie Verona Pharma PLC Put Options Transaction History
Maverick Capital LTD
- $4.82 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VRNA
# of Institutions
166Shares Held
68.7MCall Options Held
704KPut Options Held
685K-
Perceptive Advisors LLC New York, NY6.32MShares$239 Million4.75% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$211 Million12.27% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.01MShares$190 Million2.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$134 Million14.95% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$128 Million5.24% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.31B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...